PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, 643001, Tamilnadu, India.\', \'Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, 643001, Tamilnadu, India. Electronic address: ncsekar@jssuni.edu.in.\', \'Biochemistry and Drug Discovery Lab, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Guwahati, 35, Assam, India.\', \'School of Biotechnology, Laboratory of Molecular Biology and Genetic Engineering, JNU, New Delhi, 110067 India.\', \'JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, 643001, Tamilnadu, India. Electronic address: mjnanjan@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0014-2999(21)00235-110.1016/j.ejphar.2021.174082
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33823185
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
?:title
  • Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33823185>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33823185>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all